Axq Capital, LP Novo Nordisk A S Transaction History

Axq Capital, LP

  • $331 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $1.49 Million - $1.98 Million
-14,600 Reduced 76.84%
4,400 $565 Million
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $921,690 - $1.11 Million
10,500 Added 123.53%
19,000 $1.97 Billion
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $772,990 - $1.7 Million
8,500 New
8,500 $773 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email